Mayne Pharma Group Limited

ASX (AUD): Mayne Pharma Group Limited (MYX)

Last Price

5.10

Today's Change

+0.32 (6.69%)

Day's Change

4.81 - 5.17

Trading Volume

191,744

Profile
MYX

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Shawn Patrick O'Brien B.Sc Mr. Shawn Patrick O'Brien B.Sc

Full Time Employees:  850 850

IPO Date:  2007-06-29 2007-06-29

CIK: 

ISIN:  AU000000MYX0 AU000000MYX0

CUSIP:  Q5857C108 Q5857C108

Beta:  1.25 1.25

Last Dividend:  0.00 0.00

Dcf Diff:  6.11 6.11

Dcf:  -1.73 -1.73

Description

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Address

1538 Main North Road,
Salisbury South, SA 5106, AU

61 8 8209 2666

http://www.maynepharma.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment